Further to that point - Actually IMHO, the "presence" of skin in the game can also influence how directors make decisions on the raising of capital.
It's all to do with how *much* "skin"
To little- don't really care how it's done. Just get the capital.
To much - care a lot. As in "do I actually have the personal financial capacity *myself* to support it?"
All IMHO. Go Admedus. GLTAH. I wish you well.
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-249
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$10.20 |
Change
-0.550(5.12%) |
Mkt cap ! $215.6M |
Open | High | Low | Value | Volume |
$10.73 | $10.73 | $10.15 | $109.7K | 10.66K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 490 | $10.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$10.20 | 911 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 34 | 10.150 |
1 | 270 | 10.050 |
1 | 50 | 10.010 |
2 | 900 | 10.000 |
1 | 80 | 9.950 |
Price($) | Vol. | No. |
---|---|---|
10.590 | 94 | 1 |
10.750 | 413 | 1 |
11.800 | 200 | 1 |
12.000 | 5000 | 1 |
12.020 | 1000 | 1 |
Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |